Literature DB >> 28946125

A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma.

S Lefeuvre1, J Bois-Maublanc2, L Hocqueloux3, L Bret4, T Francia2, C Eleout-Da Violante5, E M Billaud6, F Barbier7, L Got2.   

Abstract

Antibiotic (ATB) treatment of critically ill patients with pathophysiological injuries remains a challenge due to the constant increase in antimicrobial resistance. Therapeutic drug monitoring (TDM) is advised for ATB dose adjustments to avoid suboptimal concentrations and dose-related adverse effects. Therefore, a single and reliable analytical method for a broad selection of ATBs was developed using a high-resolution mass spectrometry (HRMS) platform for frequent use in intensive care units. An UHPLC assay coupled to high resolution accurate mass acquisition has been developed for the quantification of penicillins (amoxicillin, oxacillin, piperacillin, and ticarcillin), cephalosporines (cefepime, cefotaxime, ceftazidime, and ceftriaxone), carbapenems (ertapenem, imipenem, and meropenem), lincosamide (clindamycin), quinolones (ofloxacin and ciprofloxacin) and tazobactam. Plasma samples (100μL) were spiked with an internal standard solution followed by protein precipitation. Separation was achieved on an Accucore C18 column, which enabled sample analysis every 9min. All compounds were detected in electrospray positive ion mode and quantified with a linear regression between 0.5 and 32mg/L (r2>0.998). Overall precision and accuracy did not exceed 15%. No significant matrix effect was observed for the studied ATBs. Stored stock solutions at -20°C were stable for 6 months, except for amoxicillin and imipenem. Analytes in plasma were stable for 24h under ambient conditions as well as in post-preparation in an autosampler, except for amoxicillin and imipenem. This HRMS assay provides the simultaneous quantification of 15 ATB; it fulfills the usual quality criteria and was successfully applied for routine TDM of ATBs. The method is based on a full scan acquisition, and it would be easy to add other compounds to the present panel in the future, as this assay has already been proven to be efficient for different classes of compounds.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critical care medecine; LC–HRMS; Quinolones antibiotics; Therapeutic drug monitoring; β-Lactam antibiotics

Mesh:

Substances:

Year:  2017        PMID: 28946125     DOI: 10.1016/j.jchromb.2017.09.014

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  A semi-automated, isotope-dilution high-resolution mass spectrometry assay for therapeutic drug monitoring of antidepressants.

Authors:  Johanna M Lindner; Michael Vogeser; Katharina Sorg; Stefanie H Grimm
Journal:  Clin Mass Spectrom       Date:  2019-05-21

Review 2.  Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.

Authors:  Johanna Kuhlin; Marieke G G Sturkenboom; Samiksha Ghimire; Ioana Margineanu; Simone H J van den Elsen; Noviana Simbar; Onno W Akkerman; Erwin M Jongedijk; Remco A Koster; Judith Bruchfeld; Daan J Touw; Jan-Willem C Alffenaar
Journal:  Clin Mass Spectrom       Date:  2018-10-19

3.  Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients.

Authors:  Sophie Neugebauer; Christina Wichmann; Sibylle Bremer-Streck; Stefan Hagel; Michael Kiehntopf
Journal:  Ther Drug Monit       Date:  2019-02       Impact factor: 3.681

4.  Detection of Oxytetracycline Using an Electrochemical Label-Free Aptamer-Based Biosensor.

Authors:  Sanaz Akbarzadeh; Habibollah Khajehsharifi; Saeedeh Hajihosseini
Journal:  Biosensors (Basel)       Date:  2022-06-28

5.  Determination of ceftriaxone in human plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Thamrong Wongchang; Markus Winterberg; Joel Tarning; Natthida Sriboonvorakul; Sant Muangnoicharoen; Daniel Blessborn
Journal:  Wellcome Open Res       Date:  2021-09-03

6.  Dried Plasma Spot Based LC-MS/MS Method for Monitoring of Meropenem in the Blood of Treated Patients.

Authors:  Haiwei Cao; Yi Jiang; Shaomin Wang; Haihuan Cao; Yanyan Li; Jing Huang
Journal:  Molecules       Date:  2022-03-19       Impact factor: 4.411

7.  Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring.

Authors:  Catherine Feliu; Celine Konecki; Tristan Candau; Damien Vautier; Cyril Haudecoeur; Claire Gozalo; Yoann Cazaubon; Zoubir Djerada
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.